Prelamin A protein causes accelerated ageing disorders and also prevents the spread of cancer cells

August 12, 2013, Wellcome Trust Sanger Institute
Absence of progeroid phenotype in ZMPSTE24 mosaic mice. (a) Breeding scheme. ZMPSTE24/HprtZ24 male mice were bred with ZMPSTE24þ/Hprtþ/þ female mice to yield female offspring that were either ZMPSTE24/HprtZ24/þ (mosaic) or ZMPSTE24þ/HprtZ24/þ (HTcontrol). DOI: 10.1038/ncomms3268

Researchers have found that a protein responsible for accelerated aging disorders can dramatically slow down the spread of cancers.

The team revealed that prelamin A, responsible for accelerated ageing in a condition called progeria, can prevent the progression of malignant or cancerous tumours. They achieved this by using mosaic mouse models, genetically modified bearing the prelamin A in half of their cells.

Ageing and cancer are intimately related processes, but their links are complex. The risk of developing tumours increases with age, but some of the mechanisms favouring ageing can also slow down the appearance and development of cancer. The results from this study represent an advance in the understanding of the underlying that link age and , as well as possible new in the future.

"Mice with prelamin A in all their cells more quickly and do not live longer than 4-5 months, which extremely hampers the study of cancer, as there is no time for the disease to fully develop," indicates Jorge de la Rosa, first author from Instituto de Medicina Oncológica y Molecular de Asturias.

Researchers previously developed mice that have an underactive ZMPSTE24 gene that mimic the ageing disorder progeria to test for possible treatments. This causes the protein prelamin A to accumulate and in turn results in progeria. To better study the association of ageing and cancer development, the team developed a mosaic model where ZMPSTE24 was underactive in half of the cells and working normally in the other half of the cells.

"Mosaic mice, however, live as long as normal mice, up to two to three years, and they keep 50% of cells with prelamin A in all their tissues throughout , which has permitted us to study the effect of this protein on cancer," comments Juan Cadiñanos, lead author from the Instituto de Medicina Oncológica y Molecular de Asturias.

The team found that the mosaic mice were completely healthy, without any of the physical deformities shown by mice with prelamin A-induced progeria: reduced size and weight, loss of fat, infertility and premature death. This suggests that it might not be necessary to correct the defects in all the cells of patients with progeria, but only some. These results provide hope for a successful treatment of patients with in the future.

The team studied the development of tumours such as skin, lung and mouth cancers in the mosaic mice. Although the mosaic mice developed the same number of tumours as normal mice, they had fewer cancerous or malignant tumours - tumours cells that can break through the biological barriers that confine them and spread to other tissues in the body. They could also check the anti-invasive effect of prelamin A on human oral, lung and breast cancer cells.

Accumulation of prelamin A in appears not to stop or reduce the initiation and development of tumour growth, but greatly reduces the capacity of the tumour to become cancerous and spread to other parts of the body. The role prelamin A has to prevent the invasion of cancer suggests that ZMPSTE24 could be an attractive new target for cancer therapy.

"Our results are extremely exciting and offer great potential for the development of new therapies against both cancer and accelerated ageing disorders," says Dr Allan Bradley, author from the Wellcome Trust Sanger Institute. "These mouse models are invaluable for understanding the origins of disease and also to inspire new treatments against these debilitating conditions."

Explore further: Promising treatment for progeria within reach

More information: de la Rosa, J. et al. Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion? Nature Communications 2013. DOI: 10.1038/ncomms3268

Related Stories

Promising treatment for progeria within reach

May 16, 2013
Pharmaceuticals that inhibit a specific enzyme may be useful in treating progeria, or accelerated aging in children. A new study performed at the Sahlgrenska Academy indicates that the development of progeria in mice was ...

Alternative target for breast cancer drugs

July 19, 2013
Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Research in mice identifies new treatment options for bowel cancer

July 8, 2013
Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised ...

Blocking key enzyme in cancer cells could lead to new therapy

August 1, 2013
Researchers from the University of Illinois at Chicago College of Medicine have identified a characteristic unique to cancer cells in an animal model of cancer—and they believe it could be exploited as a target to develop ...

Cancer stem cells isolated from kidney tumors

December 13, 2012
Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children. The researchers have used these cancer stem cells to test a new therapeutic ...

Recommended for you

Scientists produce human intestinal lining that re-creates living tissue inside organ-chip

February 16, 2018
Investigators have demonstrated how cells of a human intestinal lining created outside an individual's body mirror living tissue when placed inside microengineered Intestine-Chips, opening the door to personalized testing ...

Researcher explains how statistics, neuroscience improve anesthesiology

February 16, 2018
It's intuitive that anesthesia operates in the brain, but the standard protocol among anesthesiologists when monitoring and dosing patients during surgery is to rely on indirect signs of arousal like movement, and changes ...

Team reports progress in pursuit of sickle cell cure

February 16, 2018
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.

Data wave hits health care

February 16, 2018
Technology used by Facebook, Google and Amazon to turn spoken language into text, recognize faces and target advertising could help doctors fight one of the deadliest infections in American hospitals.

Appetite-controlling molecule could prevent 'rebound' weight gain after dieting

February 15, 2018
Scientists have revealed how mice control their appetite when under stress such as cold temperatures and starvation, according to a new study by Monash University and St Vincent's Institute in Melbourne. The results shed ...

First study of radiation exposure in human gut Organ Chip device offers hope for better radioprotective drugs

February 14, 2018
Chernobyl. Three Mile Island. Fukushima. Accidents at nuclear power plants can potentially cause massive destruction and expose workers and civilians to dangerous levels of radiation that lead to cancerous genetic mutations ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.